These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 17598237)

  • 21. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Miller WL
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1304. PubMed ID: 9100612
    [No Abstract]   [Full Text] [Related]  

  • 22. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes.
    Koppens PF; Hoogenboezem T; Degenhart HJ
    Hum Genet; 2002 Oct; 111(4-5):405-10. PubMed ID: 12384784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation.
    Araujo RS; Billerbeck AE; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):132-6. PubMed ID: 15670187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency.
    Chu X; Ding H; Cui G; Xu Y; Wang DW; He Y
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):927-8. PubMed ID: 23927611
    [No Abstract]   [Full Text] [Related]  

  • 26. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency.
    Araújo RS; Mendonca BB; Barbosa AS; Lin CJ; Marcondes JA; Billerbeck AE; Bachega TA
    J Clin Endocrinol Metab; 2007 Oct; 92(10):4028-34. PubMed ID: 17666484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characterization of new splicing mutation in steroid 21-hydroxylase gene].
    Rubtsov PM; Igudin EL; Pichugina MIu; Spirin PV; Prasolov VS; Tul'pakov AN
    Bioorg Khim; 2011; 37(6):815-20. PubMed ID: 22497080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comment on congenital adrenal hyperplasia without demonstrable genetic mutations.
    White PC
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2976-7. PubMed ID: 10443708
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency.
    Barbat B; Bogyo A; Raux-Demay MC; Kuttenn F; Boué J; Simon-Bouy B; Serre JL; Mornet E
    Hum Mutat; 1995; 5(2):126-30. PubMed ID: 7749410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplex ligation-dependent probe amplification analysis is useful for diagnosing congenital adrenal hyperplasia but requires a deep knowledge of CYP21A2 genetics.
    Concolino P; Mello E; Minucci A; Zuppi C; Capoluongo E
    Clin Chem; 2011 Jul; 57(7):1079-80. PubMed ID: 21507910
    [No Abstract]   [Full Text] [Related]  

  • 31. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations.
    Nimkarn S; Cerame BI; Wei JQ; Dumic M; Zunec R; Brkljacic L; Skrabić V; New MI; Wilson RC
    J Clin Endocrinol Metab; 1999 Jan; 84(1):378-81. PubMed ID: 9920112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.
    Wedell A
    Clin Lab Med; 1996 Mar; 16(1):125-37. PubMed ID: 8867587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predisposition for de novo gene aberrations in the offspring of mothers with a duplicated CYP21A2 gene.
    Baumgartner-Parzer SM; Fischer G; Vierhapper H
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1164-7. PubMed ID: 17164306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary amenorrhoea associated with high serum 17-hydroxyprogesterone levels revealing a heterozygous CYP21A2 mutation in a woman with Addison disease.
    Boscolo M; Bry-Gauillard H; Tardy V; Young J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):620-2. PubMed ID: 25353971
    [No Abstract]   [Full Text] [Related]  

  • 35. A 42-year-old man presented with adrenal incidentaloma due to non-classic congenital adrenal hyperplasia with a novel CYP21A2 mutation.
    Falhammar H; Torpy DJ
    Intern Med J; 2016 Sep; 46(9):1115-6. PubMed ID: 27633475
    [No Abstract]   [Full Text] [Related]  

  • 36. CH-8 Phenotype in steroid 21-hydroxylase deficiency: fact or fancy?
    Lee HH
    Clin Chem; 2012 Nov; 58(11):1600-1. PubMed ID: 22908133
    [No Abstract]   [Full Text] [Related]  

  • 37. CYPs, SNPs, and molecular diagnosis in the postgenomic era.
    Vilain E
    Clin Chem; 1998 Dec; 44(12):2403-4. PubMed ID: 9836703
    [No Abstract]   [Full Text] [Related]  

  • 38. Heterozygous POR gene mutations in a patient with congenital adrenal hyperplasia.
    Gusmano C; Calogero AE; Cannarella R
    Endocrine; 2022 Aug; 77(2):401-402. PubMed ID: 35635658
    [No Abstract]   [Full Text] [Related]  

  • 39. CYP21A2 genetics: When genotype does not fit phenotype.
    Sani I; Rossodivita AN; Mariani M; Costella A; Molinario R; Concolino P; Capoluongo E
    Clin Biochem; 2016 Apr; 49(6):524-525. PubMed ID: 26209023
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia".
    Marino R; Perez Garrido N; Ramirez P; Belgorosky A
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2837-e2838. PubMed ID: 33901286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.